Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.
Financial Results:
Ipca Laboratories Ltd reported Revenues for Q2FY25 of ₹2,355.00 Crores up from ₹2,034.00 Crore year on year, a rise of 15.78%.
Total Expenses for Q2FY25 of ₹2,036.00 Crores up from ₹1,807.00 Crores year on year, a rise of 12.67%.
Consolidated Net Profit of ₹246.00 Crores up 80.88% from ₹136.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.05, up 58.22% from ₹5.72 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.